Literature DB >> 23726869

Psychiatric comorbidity among adults with schizophrenia: a latent class analysis.

Jack Tsai1, Robert A Rosenheck.   

Abstract

Schizophrenia is a severe mental illness that often co-occurs with and can be exacerbated by other psychiatric conditions. There have not been adequate efforts to examine schizophrenia and psychiatric comorbidity beyond pairwise examination using clusters of diagnoses. This study used latent class analysis to characterize patterns of 5-year psychiatric comorbidity among a national sample of adults with schizophrenia. Baseline data from 1446 adults with schizophrenia across 57 sites in the United States were analyzed. Three latent classes were identified labeled Solely Schizophrenia, Comorbid Anxiety and Depressive Disorders with Schizophrenia, and Comorbid Addiction and Schizophrenia. Adults in the Solely Schizophrenia class had significantly better mental health than those in the two comorbid classes, but poorer illness and treatment insight than those with comorbid anxiety and depressive disorders. These results suggest that addiction and schizophrenia may represent a separate latent profile from depression, anxiety, and schizophrenia. More research is needed on how treatment can take advantage of the greater insight possessed by those with schizophrenia and comorbid anxiety and depression. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Anxiety; Classification; Depression; Diagnosis; Methods; Substance-related disorders

Mesh:

Year:  2013        PMID: 23726869      PMCID: PMC3800495          DOI: 10.1016/j.psychres.2013.05.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  35 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

2.  Management of persons with co-occurring severe mental illness and substance use disorder: program implications.

Authors:  Robert E Drake; Kim T Mueser; Mary F Brunette
Journal:  World Psychiatry       Date:  2007-10       Impact factor: 49.548

3.  Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.

Authors:  Kang Sim; Rathi Mahendran; Samuel G Siris; Stephan Heckers; Siow Ann Chong
Journal:  Psychiatry Res       Date:  2004-12-15       Impact factor: 3.222

4.  Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.

Authors:  Philip Tibbo; Jennifer Swainson; Pierre Chue; Jean-Michel LeMelledo
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

5.  Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

Authors:  R A Emsley; P P Oosthuizen; A F Joubert; M C Roberts; D J Stein
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

6.  Mood and alcohol consumption: an experience sampling test of the self-medication hypothesis.

Authors:  J D Swendsen; H Tennen; M A Carney; G Affleck; A Willard; A Hromi
Journal:  J Abnorm Psychol       Date:  2000-05

Review 7.  Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?

Authors:  Alexandra Bottas; Robert G Cooke; Margaret A Richter
Journal:  J Psychiatry Neurosci       Date:  2005-05       Impact factor: 6.186

8.  Insight in schizophrenia. Its relationship to acute psychopathology.

Authors:  J P McEvoy; L J Apperson; P S Appelbaum; P Ortlip; J Brecosky; K Hammill; J L Geller; L Roth
Journal:  J Nerv Ment Dis       Date:  1989-01       Impact factor: 2.254

Review 9.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

Review 10.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

View more
  19 in total

1.  The mediating effect of family cohesion in reducing patient symptoms and family distress in a culturally informed family therapy for schizophrenia: A parallel-process latent-growth model.

Authors:  Caitlin A Brown; Amy Weisman de Mamani
Journal:  J Consult Clin Psychol       Date:  2017-11-27

Review 2.  Anxiety in Patients with Schizophrenia: Epidemiology and Management.

Authors:  Henk Temmingh; Dan J Stein
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

3.  CBT for severe mental disorder: a good product that is in danger of being over-extended.

Authors:  Peter Tyrer
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

4.  Comorbid substance use disorders in schizophrenia: a latent class approach.

Authors:  Berit Kerner
Journal:  Psychiatry Res       Date:  2014-12-15       Impact factor: 3.222

Review 5.  [Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment].

Authors:  Frederike Schirmbeck; Mathias Zink
Journal:  Nervenarzt       Date:  2022-07-05       Impact factor: 1.297

6.  Physical and psychiatric comorbidities among patients with severe mental illness as seen in Uganda.

Authors:  Richard Stephen Mpango; Wilber Ssembajjwe; Godfrey Zari Rukundo; Carol Birungi; Allan Kalungi; Kenneth D Gadow; Vikram Patel; Moffat Nyirenda; Eugene Kinyanda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-24       Impact factor: 5.760

7.  Unemployment, homelessness, and other societal outcomes in patients with schizophrenia: a real-world retrospective cohort study of the United States Veterans Health Administration database : Societal burden of schizophrenia among US veterans.

Authors:  Dee Lin; Hyunchung Kim; Keiko Wada; Maya Aboumrad; Ethan Powell; Gabrielle Zwain; Carmela Benson; Aimee M Near
Journal:  BMC Psychiatry       Date:  2022-07-08       Impact factor: 4.144

Review 8.  Clinical characteristics and treatment outcomes of patients with newly diagnosed schizophrenia: A 4-year single-center experience in Saudi Arabia.

Authors:  Tahir Hakami
Journal:  Neuropsychopharmacol Rep       Date:  2022-03-22

9.  Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings.

Authors:  Lukasz Smigielski; Vinita Jagannath; Wulf Rössler; Susanne Walitza; Edna Grünblatt
Journal:  Mol Psychiatry       Date:  2020-01-06       Impact factor: 15.992

Review 10.  Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review.

Authors:  Megan Anne Arroll; Lorraine Wilder; James Neil
Journal:  Nutr J       Date:  2014-09-16       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.